MedTrace Logo

Endoplasmic Reticulum Stress and Resistance to Treatments in Ph-negative Myeloproliferative Neoplasms

NCT02823184 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 148

Last updated 2020-06-19

No results posted yet for this study

Summary

The aim of this study is to evaluate the endoplasmic reticulum stress markers as predictive for response to hydroxyurea in polycythemia vera (PV) and essential thrombocythemia (ET).

Conditions

Interventions

BIOLOGICAL

RNA sample of total leukocytes before start of treatment

RNA sample of total leukocytes before start of treatment

Sponsors & Collaborators

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Olivier MANSIER, Doctor · University Hospital, Bordeaux

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-27
Primary Completion
2019-04-27
Completion
2019-04-27

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02823184 on ClinicalTrials.gov